Merck: What Makes This Big Pharma Tick In April 2020 [Seeking Alpha]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Seeking Alpha
SummaryKeytruda continues to be the shining star in Merck's arsenal.The company is a safe dividend stock with robust financials.Investors should be aware of risks such as business concentration risk and R&D failure risks.Once a darling of the stock market, Merck (MRKToday, Merck is one of the few reliable dividend stocks income investors can rely on. This is exceptional in current times when many companies are either suspending or cutting dividend payments. Merck is also less likely to see a significant hit to demand, considering that its products mostly target cancer patients and patients suffering from other chronic and often fatal diseases. Hence, the chances of patients foregoing these medications due to the COVID-19 pandemic remain slim. The company's lead asset, Keytruda, continues to be the preferred immunotherapy, both as monotherapy and in combination with other agents, across multiple cancer indications.Merck is a safe dividend stock with solid financial prospectsCurrently,
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck Trials, Tempus AI Deal And Leadership Shifts Shape Valuation Story [Yahoo! Finance]Yahoo! Finance
- Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial [Yahoo! Finance]Yahoo! Finance
- Akeso Deepens Cadonilimab Story With Survival Data And Global GBM Trial [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Up 1.7% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]Yahoo! Finance
- Evaxion announces business update and full year 2025 financial results [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 2/24/26 - Form 10-K
- 2/17/26 - Form 13F-HR
- 2/13/26 - Form 144/A
- MRK's page on the SEC website